Precision Business Insights
Portfolio

 

Research Reports

Platelet Rich Plasma (PRP) Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global Platelet Rich Plasma (PRP) Market

 

By Product Type (Pure Platelet Rich Plasma, Pure Platelet Rich Fibrin, Leukocyte-Platelet Rich Fibrin, Others), By Application (General Surgery, Neurosurgery, Cardiac Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global platelet rich plasma (PRP) market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024.

 

Market Outline: Global Platelet Rich Plasma (PRP) Market

Platelet rich plasma (PRP) is a permanent solution for various conditions such as ligament/tendon sprains, arthritis, and tears. Platelet rich plasma (PRP) therapy is usually done by utilizing the body’s natural healing process. In this therapy, the concentration of platelets are injected into the damaged tendons, joints and ligaments in order to accelerate healing that anticipates tissue repair. The platelets are considered to be rich in growth and healing factors. The Platelet rich plasma (PRP) injections are used in the treatment of various conditions such as shoulder pain and instability, lumbar spine disc pain, knee sprains and instability, hamstring and hip strains, ankle sprains, knee, hip, and other joint osteoarthritis among others.

Market Dynamics: Global Platelet Rich Plasma (PRP) Market

Increase in the geriatric population along with increase in health issues are the key factors attributing the growth of Platelet rich plasma (PRP) market. The rising applications of platelet rich plasma (PRP) in various areas anticipated to fuel the growth of the market. The soaring use of PRP application in the cosmetic surgeries is boosting the growth of the market. The successful application of PRP in the orthopedic disorders such as Achilles tendinopathy, knee osteoarthritis, rotator cuff tears, and lateral epicondylitis has enhanced the growth of the Platelet rich plasma market. Growing incidence of sport injuries is adding scope for further growth in the market. However, the high risk of contamination owing to improper storage is hampering the growth of the market. The difficulty in quality control of test results is hindering the growth of the Platelet rich plasma market.

 

Market Scope: Global Platelet Rich Plasma (PRP) Market

Platelet rich plasma (PRP) market is segmented on the basis of product type, application, and end user

Based on the product type, the market is segmented into the following:

  • Pure Platelet Rich Plasma
  • Pure Platelet Rich Fibrin
  • Leukocyte-Platelet Rich Fibrin
  • Others

Based on the application, the market is segmented into the following:

  • General Surgery
  • Neurosurgery
  • Cardiac Surgery
  • Orthopedic Surgery
  • Others

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others

 

Regional Analysis: Global Platelet Rich Plasma (PRP) Market

Geographically, global platelet rich plasma (PRP) market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America platelet rich plasma (PRP) market is set to expand at significant CAGR owing to increase in the number of surgeries due to rise in prevalence of cardiac and neurodegenerative disorders, advancements in healthcare technology, and presence of significant market players in the North America. Europe platelet rich plasma (PRP) market has lucrative growth attributed to increase in demand for cosmetic surgeries, increase in the number of sports injuries, and rise in focus on R&D to develop the newer products are anticipated to propel the market. However, Asia Pacific platelet rich plasma (PRP) market is poised to grow due to entry of market players into Asia Pacific countries, increase in the number of surgical procedures due to rise in medical tourism, and grow in geriatric population in India and China are surge the market

 

Competition Assessment: Global Platelet Rich Plasma (PRP) Market

Some of the players in the global platelet rich plasma (PRP) market include:

  • Bio Products Laboratory Ltd. (BPL) (UK)
  • Cambryn Biologics LLC (U.S.)
  • CSL Ltd. (Australia)
  • Kedrion S.p.A. (Italy)
  • China Biologic Products, Inc. (China)
  • LFB S.A. (France)
  • Grifols International S.A. (Spain)
  • Octapharma (Switzerland)
  • BioLife Plasma Services (U.S.)
  • Biotest (Germany)

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0
  • Bio Products Laboratory Ltd. (BPL) (UK)
  • Cambryn Biologics LLC (U.S.)
  • CSL Ltd. (Australia)
  • Kedrion S.p.A. (Italy)
  • China Biologic Products, Inc. (China)
  • LFB S.A. (France)
  • Grifols International S.A. (Spain)
  • Octapharma (Switzerland)
  • BioLife Plasma Services (U.S.)
  • Biotest (Germany)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Contact SalesTOLL FREE: +1-866-598-1553